United States Biotechnology & Medical Research

Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics executives have engaged in multiple planned divestments recently. Chief Medical Officer Carl Dambkowski and CEO Michael Henderson executed several sales, totaling significant share volumes. These transactions occurred while the stock price traded near its fifty-two-week peak, following the latest earnings report which showed a slight miss in earnings per share expectations.
Ticker: APGE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Apogee Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
126.75
Quantity 84,270 +10.1%
Value US$3,411,078
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
386.77
Quantity 79,213 -6.5%
Value US$2,244,473
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
353.60
Quantity 62,265 -7.5%
Value US$3,183,597
CARL DAMBKOWSKI Officer Officer
Transaction date
Proposed sale
Price
132.73
Quantity 16,500
Value US$2,190,045
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
132.54
Quantity 80,000 -7.3%
Value US$10,603,200
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
132.60
Quantity 26,400 -12.8%
Value US$3,500,640
HENDERSON MICHAEL THOMAS Officer; Director Executive Director
Transaction date
Proposed sale
Price
132.54
Quantity 80,000
Value US$10,603,532
HENDERSON MICHAEL THOMAS Officer; Director Executive Director
Transaction date
Proposed sale
Price
132.54
Quantity 80,000
Value US$10,603,532
CARL DAMBKOWSKI Officer Officer
Transaction date
Proposed sale
Price
90.38
Quantity 15,400
Value US$1,391,852
CARL DAMBKOWSKI Officer Officer
Transaction date
Proposed sale
Price
90.38
Quantity 15,400
Value US$1,391,852
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
86.89
Quantity 614 -0.1%
Value US$53,350
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
86.27
Quantity 2,305 -0.2%
Value US$198,852
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.19
Quantity 1,577 -0.1%
Value US$134,345
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.18
Quantity 1,080 -0.1%
Value US$90,914
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.78
Quantity 7,654 -0.7%
Value US$633,598
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
86.89
Quantity 614 -0.1%
Value US$53,350
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
86.27
Quantity 2,305 -0.2%
Value US$198,852
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.19
Quantity 1,577 -0.1%
Value US$134,345
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.18
Quantity 1,080 -0.1%
Value US$90,914
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.78
Quantity 7,654 -0.7%
Value US$633,598
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.21
Quantity 6,770 -0.6%
Value US$556,562
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
78.71
Quantity 5,500 -2.6%
Value US$432,905
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.58
Quantity 1,341 -0.1%
Value US$110,740
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.05
Quantity 18,659 -1.6%
Value US$1,530,971
HENDERSON MICHAEL THOMAS Officer; Director Executive Director
Transaction date
Proposed sale
Price
82.47
Quantity 60,000
Value US$4,948,200
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.60
Quantity 1,800 -0.9%
Value US$152,280
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
83.92
Quantity 3,700 -1.7%
Value US$310,504
CARL DAMBKOWSKI Officer Officer
Transaction date
Proposed sale
Price
83.29
Quantity 22,000
Value US$1,832,380
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
83.16
Quantity 289 -0.2%
Value US$24,033
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
82.60
Quantity 900 -0.5%
Value US$74,340
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
81.02
Quantity 811 -0.5%
Value US$65,707
3.6
JANE HENDERSON Officer Officer
Transaction date
Proposed sale
Price
82.89
Quantity 2,000
Value US$165,780
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
90.00
Quantity 2,000 -1.1%
Value US$180,000
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.00
Quantity 200 -0.0%
Value US$17,000
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
83.26
Quantity 2,000 -0.2%
Value US$166,520
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
82.48
Quantity 17,800 -1.5%
Value US$1,468,144
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.89
Quantity 100 -0.0%
Value US$8,589
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.33
Quantity 2,702 -1.3%
Value US$230,562
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.31
Quantity 2,698 -1.3%
Value US$227,468
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
85.46
Quantity 1,100 -0.6%
Value US$94,006
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
84.46
Quantity 900 -0.5%
Value US$76,014
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
85.00
Quantity 2,000 -1.1%
Value US$170,000
3.6
JANE HENDERSON Officer Officer
Transaction date
Proposed sale
Price
73.00
Quantity 6,000
Value US$438,000
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
75.86
Quantity 3,418 -0.3%
Value US$259,289
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
74.83
Quantity 8,219 -0.7%
Value US$615,028
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
74.29
Quantity 8,363 -0.7%
Value US$621,287
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
73.26
Quantity 200 -0.1%
Value US$14,652
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
71.98
Quantity 2,075 -1.0%
Value US$149,358
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
70.33
Quantity 3,225 -1.5%
Value US$226,814
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
71.66
Quantity 406 -0.2%
Value US$29,094
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
70.45
Quantity 994 -0.5%
Value US$70,027
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
69.43
Quantity 300 -0.2%
Value US$20,829
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
68.27
Quantity 300 -0.2%
Value US$20,481
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
64.99
Quantity 955 -0.1%
Value US$62,065
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
63.73
Quantity 7,551 -0.6%
Value US$481,225
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
62.96
Quantity 11,494 -1.0%
Value US$723,662
HENDERSON MICHAEL THOMAS Officer; Director Executive Director
Transaction date
Proposed sale
Price
64.00
Quantity 60,000
Value US$3,840,000
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
68.94
Quantity 200 -0.1%
Value US$13,788
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
67.88
Quantity 100 -0.0%
Value US$6,788
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
66.85
Quantity 1,299 -0.6%
Value US$86,838
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
65.83
Quantity 1,420 -0.7%
Value US$93,479
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
64.88
Quantity 2,481 -1.1%
Value US$160,967
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
68.94
Quantity 200 -0.1%
Value US$13,788
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
67.88
Quantity 100 -0.0%
Value US$6,788
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
66.85
Quantity 1,299 -0.6%
Value US$86,838
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
65.83
Quantity 1,420 -0.7%
Value US$93,479
Dambkowski Carl Chief Medical Officer Officer
Transaction date
Planned sale
Price
64.88
Quantity 2,481 -1.1%
Value US$160,967
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
66.89
Quantity 100 -0.1%
Value US$6,689
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
66.15
Quantity 1,108 -0.6%
Value US$73,294
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
66.89
Quantity 100 -0.1%
Value US$6,689
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
66.15
Quantity 1,108 -0.6%
Value US$73,294
3.6
Henderson Jane Chief Financial Officer Officer
Transaction date
Planned sale
Price
65.21
Quantity 792 -0.4%
Value US$51,646
HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
83.79
Quantity 470 -0.0%
Value US$39,381
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-05 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
84,270 +10.1%
126.75
US$3,411,078 		84,270 +10.1% 126.75 US$3,411,078
2026-07-10 2026-07-08 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
79,213 -6.5%
386.77
US$2,244,473 		79,213 -6.5% 386.77 US$2,244,473
2026-07-02 2026-07-01 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
62,265 -7.5%
353.60
US$3,183,597 		62,265 -7.5% 353.60 US$3,183,597
2026-07-01 2026-07-01 PrS Proposed sale
CARL DAMBKOWSKI

Officer

Officer
16,500
132.73
US$2,190,045 		16,500 132.73 US$2,190,045
2026-06-24 2026-06-22 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
80,000 -7.3%
132.54
US$10,603,200 		80,000 -7.3% 132.54 US$10,603,200
2026-06-24 2026-06-22 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
26,400 -12.8%
132.60
US$3,500,640 		26,400 -12.8% 132.60 US$3,500,640
2026-06-22 2026-06-22 PrS Proposed sale
HENDERSON MICHAEL THOMAS

Officer; Director

Executive Director
80,000
132.54
US$10,603,532 		80,000 132.54 US$10,603,532
2026-06-22 2026-06-22 PrS Proposed sale
HENDERSON MICHAEL THOMAS

Officer; Director

Executive Director
80,000
132.54
US$10,603,532 		80,000 132.54 US$10,603,532
2026-06-22 2026-06-22 PrS Proposed sale
CARL DAMBKOWSKI

Officer

Officer
15,400
90.38
US$1,391,852 		15,400 90.38 US$1,391,852
2026-06-22 2026-06-22 PrS Proposed sale
CARL DAMBKOWSKI

Officer

Officer
15,400
90.38
US$1,391,852 		15,400 90.38 US$1,391,852
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
614 -0.1%
86.89
US$53,350 		614 -0.1% 86.89 US$53,350
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
2,305 -0.2%
86.27
US$198,852 		2,305 -0.2% 86.27 US$198,852
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
1,577 -0.1%
85.19
US$134,345 		1,577 -0.1% 85.19 US$134,345
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
1,080 -0.1%
84.18
US$90,914 		1,080 -0.1% 84.18 US$90,914
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
7,654 -0.7%
82.78
US$633,598 		7,654 -0.7% 82.78 US$633,598
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
614 -0.1%
86.89
US$53,350 		614 -0.1% 86.89 US$53,350
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
2,305 -0.2%
86.27
US$198,852 		2,305 -0.2% 86.27 US$198,852
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
1,577 -0.1%
85.19
US$134,345 		1,577 -0.1% 85.19 US$134,345
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
1,080 -0.1%
84.18
US$90,914 		1,080 -0.1% 84.18 US$90,914
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
7,654 -0.7%
82.78
US$633,598 		7,654 -0.7% 82.78 US$633,598
2026-06-12 2026-06-10 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
6,770 -0.6%
82.21
US$556,562 		6,770 -0.6% 82.21 US$556,562
2026-06-05 2026-06-03 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
5,500 -2.6%
78.71
US$432,905 		5,500 -2.6% 78.71 US$432,905
2026-05-15 2026-05-13 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
1,341 -0.1%
82.58
US$110,740 		1,341 -0.1% 82.58 US$110,740
2026-05-15 2026-05-13 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
18,659 -1.6%
82.05
US$1,530,971 		18,659 -1.6% 82.05 US$1,530,971
2026-05-13 2026-05-13 PrS Proposed sale
HENDERSON MICHAEL THOMAS

Officer; Director

Executive Director
60,000
82.47
US$4,948,200 		60,000 82.47 US$4,948,200
2026-05-08 2026-05-06 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
1,800 -0.9%
84.60
US$152,280 		1,800 -0.9% 84.60 US$152,280
2026-05-08 2026-05-06 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
3,700 -1.7%
83.92
US$310,504 		3,700 -1.7% 83.92 US$310,504
2026-05-06 2026-05-06 PrS Proposed sale
CARL DAMBKOWSKI

Officer

Officer
22,000
83.29
US$1,832,380 		22,000 83.29 US$1,832,380
2026-05-04 2026-05-01 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
289 -0.2%
83.16
US$24,033 		289 -0.2% 83.16 US$24,033
2026-05-04 2026-05-01 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
900 -0.5%
82.60
US$74,340 		900 -0.5% 82.60 US$74,340
2026-05-04 2026-05-01 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
811 -0.5%
81.02
US$65,707 		811 -0.5% 81.02 US$65,707
2026-05-01 2026-05-01 PrS Proposed sale
3.6
JANE HENDERSON

Officer

Officer
2,000
82.89
US$165,780 		2,000 82.89 US$165,780
2026-04-17 2026-04-16 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
2,000 -1.1%
90.00
US$180,000 		2,000 -1.1% 90.00 US$180,000
2026-04-10 2026-04-08 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
200 -0.0%
85.00
US$17,000 		200 -0.0% 85.00 US$17,000
2026-04-10 2026-04-08 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
2,000 -0.2%
83.26
US$166,520 		2,000 -0.2% 83.26 US$166,520
2026-04-10 2026-04-08 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
17,800 -1.5%
82.48
US$1,468,144 		17,800 -1.5% 82.48 US$1,468,144
2026-04-03 2026-04-01 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
100 -0.0%
85.89
US$8,589 		100 -0.0% 85.89 US$8,589
2026-04-03 2026-04-01 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
2,702 -1.3%
85.33
US$230,562 		2,702 -1.3% 85.33 US$230,562
2026-04-03 2026-04-01 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
2,698 -1.3%
84.31
US$227,468 		2,698 -1.3% 84.31 US$227,468
2026-04-03 2026-04-01 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
1,100 -0.6%
85.46
US$94,006 		1,100 -0.6% 85.46 US$94,006
2026-04-03 2026-04-01 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
900 -0.5%
84.46
US$76,014 		900 -0.5% 84.46 US$76,014
2026-03-27 2026-03-25 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
2,000 -1.1%
85.00
US$170,000 		2,000 -1.1% 85.00 US$170,000
2026-03-25 2026-03-25 PrS Proposed sale
3.6
JANE HENDERSON

Officer

Officer
6,000
73.00
US$438,000 		6,000 73.00 US$438,000
2026-03-13 2026-03-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
3,418 -0.3%
75.86
US$259,289 		3,418 -0.3% 75.86 US$259,289
2026-03-13 2026-03-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
8,219 -0.7%
74.83
US$615,028 		8,219 -0.7% 74.83 US$615,028
2026-03-13 2026-03-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
8,363 -0.7%
74.29
US$621,287 		8,363 -0.7% 74.29 US$621,287
2026-03-06 2026-03-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
200 -0.1%
73.26
US$14,652 		200 -0.1% 73.26 US$14,652
2026-03-06 2026-03-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
2,075 -1.0%
71.98
US$149,358 		2,075 -1.0% 71.98 US$149,358
2026-03-06 2026-03-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
3,225 -1.5%
70.33
US$226,814 		3,225 -1.5% 70.33 US$226,814
2026-03-04 2026-03-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
406 -0.2%
71.66
US$29,094 		406 -0.2% 71.66 US$29,094
2026-03-04 2026-03-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
994 -0.5%
70.45
US$70,027 		994 -0.5% 70.45 US$70,027
2026-03-04 2026-03-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
300 -0.2%
69.43
US$20,829 		300 -0.2% 69.43 US$20,829
2026-03-04 2026-03-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
300 -0.2%
68.27
US$20,481 		300 -0.2% 68.27 US$20,481
2026-02-13 2026-02-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
955 -0.1%
64.99
US$62,065 		955 -0.1% 64.99 US$62,065
2026-02-13 2026-02-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
7,551 -0.6%
63.73
US$481,225 		7,551 -0.6% 63.73 US$481,225
2026-02-13 2026-02-11 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
11,494 -1.0%
62.96
US$723,662 		11,494 -1.0% 62.96 US$723,662
2026-02-11 2026-02-11 PrS Proposed sale
HENDERSON MICHAEL THOMAS

Officer; Director

Executive Director
60,000
64.00
US$3,840,000 		60,000 64.00 US$3,840,000
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
200 -0.1%
68.94
US$13,788 		200 -0.1% 68.94 US$13,788
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
100 -0.0%
67.88
US$6,788 		100 -0.0% 67.88 US$6,788
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
1,299 -0.6%
66.85
US$86,838 		1,299 -0.6% 66.85 US$86,838
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
1,420 -0.7%
65.83
US$93,479 		1,420 -0.7% 65.83 US$93,479
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
2,481 -1.1%
64.88
US$160,967 		2,481 -1.1% 64.88 US$160,967
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
200 -0.1%
68.94
US$13,788 		200 -0.1% 68.94 US$13,788
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
100 -0.0%
67.88
US$6,788 		100 -0.0% 67.88 US$6,788
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
1,299 -0.6%
66.85
US$86,838 		1,299 -0.6% 66.85 US$86,838
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
1,420 -0.7%
65.83
US$93,479 		1,420 -0.7% 65.83 US$93,479
2026-02-04 2026-02-04 PlS Planned sale
Dambkowski Carl

Chief Medical Officer

Officer
2,481 -1.1%
64.88
US$160,967 		2,481 -1.1% 64.88 US$160,967
2026-02-04 2026-02-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
100 -0.1%
66.89
US$6,689 		100 -0.1% 66.89 US$6,689
2026-02-04 2026-02-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
1,108 -0.6%
66.15
US$73,294 		1,108 -0.6% 66.15 US$73,294
2026-02-04 2026-02-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
100 -0.1%
66.89
US$6,689 		100 -0.1% 66.89 US$6,689
2026-02-04 2026-02-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
1,108 -0.6%
66.15
US$73,294 		1,108 -0.6% 66.15 US$73,294
2026-02-04 2026-02-02 PlS Planned sale
3.6
Henderson Jane

Chief Financial Officer

Officer
792 -0.4%
65.21
US$51,646 		792 -0.4% 65.21 US$51,646
2026-01-22 2026-01-22 PrS Proposed sale
3.3
Fairmount Healthcare Fund II L.P.

Director

Non-Executive Director
1,750,000
76.30
US$133,525,000 		1,750,000 76.30 US$133,525,000
2026-01-22 2026-01-22 S Sale
3.3
Fairmount Funds Management LLC
Non-Executive Director
1,750,000 -85.4%
76.30
US$133,525,000 		1,750,000 -85.4% 76.30 US$133,525,000
2026-01-16 2026-01-14 PlS Planned sale
HENDERSON MICHAEL THOMAS

Chief Executive Officer

Executive Director
470 -0.0%
83.79
US$39,381 		470 -0.0% 83.79 US$39,381

See older Apogee Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Apogee Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Apogee Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America